Ensign Peak Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44,021	Closed	-$239K	–	1720
2024 Q4	$239K	Buy	44,021 +1,300	+3%	+$7.95K	﹤0.01%	1690
2024 Q3	$308K	Buy	42,721 +13,200	+45%	+$121K	﹤0.01%	1672
2024 Q2	$321K	Hold	29,521	–	–	﹤0.01%	1675
2024 Q1	$553K	Sell	29,521 -1,489	-5%	-$34.3K	﹤0.01%	1598
2023 Q4	$672K	Hold	31,010	–	–	﹤0.01%	1583
2023 Q3	$638K	Hold	31,010	–	–	﹤0.01%	1501
2023 Q2	$1.46M	Hold	31,010	–	–	﹤0.01%	1003
2023 Q1	$1.3M	Hold	31,010	–	–	﹤0.01%	1033
2022 Q4	$1.18M	Buy	31,010 +15,950	+106%	+$609K	﹤0.01%	1036
2022 Q3	$590K	Buy	15,060 +7,120	+90%	+$275K	﹤0.01%	1368
2022 Q2	$256K	Hold	7,940	–	–	﹤0.01%	1721
2022 Q1	$263K	Hold	7,940	–	–	﹤0.01%	1795
2021 Q4	$338K	Sell	7,940 -13,627	-63%	-$571K	﹤0.01%	1773
2021 Q3	$956K	Sell	21,567 -7,745	-26%	-$355K	﹤0.01%	1452
2021 Q2	$1.67M	Buy	29,312 +8,752	+43%	+$619K	﹤0.01%	1225
2021 Q1	$1.54M	Sell	20,560 -5,490	-21%	-$450K	﹤0.01%	1234
2020 Q4	$2.25M	Hold	26,050	–	–	0.01%	988
2020 Q3	$1.59M	Buy	26,050 +13,066	+101%	+$662K	﹤0.01%	1097
2020 Q2	$539K	Sell	12,984 -2,115	-14%	-$76.8K	﹤0.01%	1447
2020 Q1	$433K	Sell	15,099 -4,257	-22%	-$247K	﹤0.01%	1425
2019 Q4	$1.4M	Buy	+19,356	New	+$2.38M	﹤0.01%	1207